Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2025-12-29 @ 3:58 AM
Study NCT ID:
NCT00721734
Status:
COMPLETED
Last Update Posted:
2017-05-02
First Post:
2008-07-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11
Start Date Type:
None
Primary Completion Date:
2012-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-07-22
First Submit QC Date:
None
Study First Post Date:
2008-07-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-11-02
Results First Submit QC Date:
None
Results First Post Date:
2015-12-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-28
Last Update Post Date:
2017-05-02
Last Update Post Date Type:
ACTUAL